
INDV
Healthcare · Drug Manufacturers - Specialty & Generic · $4.28B market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +15.6% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | Before the open | 0.93 | 1.32 | +41.9% |
| Aug 3, 2026 | Before the open | 0.97 | 1.15 | +18.6% |
| Apr 30, 2026 | Before the open | 0.66 | 0.96 | +45.5% |
| Feb 26, 2026 | Time not confirmed | 0.65 | 0.82 | +26.2% |
| Oct 30, 2025 | Before the open | 0.41 | 0.72 | +75.6% |
| Jul 31, 2025 | Before the open | 0.25 | 0.51 | +104.0% |
| Apr 24, 2025 | Before the open | 0.23 | 0.41 | +78.3% |
| Feb 20, 2025 | Before the open | 0.26 | 0.32 | +22.7% |
| Oct 24, 2024 | Before the open | 0.31 | 0.03 | -90.3% |
| Jul 25, 2024 | Before the open | 0.40 | 0.44 | +10.0% |
| Apr 25, 2024 | Before the open | 0.42 | 0.37 | -11.9% |
| Feb 22, 2024 | Before the open | 0.28 | 0.43 | +53.6% |
| Nov 9, 2023 | Before the open | 0.30 | 0.34 |
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine…
| +13.3% |
| Jul 27, 2023 | Before the open | 0.22 | 0.39 | +77.3% |
| Apr 27, 2023 | Time not confirmed | 0.40 | 0.40 | 0.0% |
| Feb 16, 2023 | Time not confirmed | 0.27 | -1.34 | -596.6% |
| Oct 27, 2022 | Time not confirmed | 0.29 | 0.28 | -3.4% |
| Jul 28, 2022 | Time not confirmed | 0.30 | 0.34 | +14.5% |
| Apr 28, 2022 | Time not confirmed | 0.30 | 0.28 | -8.3% |
| Feb 16, 2022 | Time not confirmed | 0.15 | 0.25 | +66.1% |
| Oct 28, 2021 | Time not confirmed | 0.15 | 0.15 | 0.0% |
| Jul 29, 2021 | Time not confirmed | 0.30 | 0.40 | +33.3% |
| Apr 29, 2021 | Time not confirmed | 0.25 | 0.51 | +104.8% |
| Feb 18, 2021 | Time not confirmed | 0.15 | -0.09 | -159.1% |
| Oct 29, 2020 | Time not confirmed | 0.10 | 0.05 | -50.0% |
| Jul 30, 2020 | Time not confirmed | 0.10 | 0.10 | 0.0% |
| May 14, 2020 | Time not confirmed | -1.10 | -1.11 | -1.2% |
| Feb 13, 2020 | Time not confirmed | -0.25 | -0.38 | -50.5% |
| Oct 31, 2019 | Time not confirmed | 0.30 | 0.30 | 0.0% |
| Jul 31, 2019 | Time not confirmed | 0.50 | 0.50 | 0.0% |
| May 2, 2019 | Time not confirmed | — | 0.44 | — |
| Feb 14, 2019 | Time not confirmed | — | 0.16 | — |
| Nov 1, 2018 | Time not confirmed | — | 0.61 | — |
| Jul 25, 2018 | Time not confirmed | — | 0.45 | — |
| May 2, 2018 | Time not confirmed | — | 0.62 | — |
| Feb 15, 2018 | Time not confirmed | — | -1.00 | — |